|
2025 Journal Article Harnessing notch signaling to enhance the generation and functionality of human conventional type I dendritic cells for cancer immunotherapy applicationsBalan, Sreekumar, O'Brien, Liam, Peros, Ante, Wang, Xuedi, Leal-Rojas, Ingrid, Mcclain, Christopher, Radford, Kristen J. and Bhardwaj, Nina (2025). Harnessing notch signaling to enhance the generation and functionality of human conventional type I dendritic cells for cancer immunotherapy applications. Cancer Immunology Research, 13 (9), 1328-1341. doi: 10.1158/2326-6066.cir-25-0034 |
|
2020 Conference Publication Human CD141+dendritic cells (cDC1) are impaired in advanced melanoma patients but can be targeted to increase efficacy of anti-PD-1 checkpoint inhibitor therapyO'Brien, Liam, Lee, Yoke Seng, Walpole, Carina, Rojas, Ingrid Leal, Masterman, Kelly-Anne, Atkinson, Victoria, Barbour, Andrew and Radford, Kristen (2020). Human CD141+dendritic cells (cDC1) are impaired in advanced melanoma patients but can be targeted to increase efficacy of anti-PD-1 checkpoint inhibitor therapy. AACR Special Conference on Tumor Immunology and Immunotherapy, Boston, MA, United States, 17-20 November, 2019. Philadelphia, PA, United States: American Association for Cancer Research. |
